Medicine Compliance Among Hypertensive Patients with Known Diabetes Mellitus in Sindh, Pakistan Compliance Among Hypertensive and Diabetic Patients in Sindh
Main Article Content
Abstract
Background: Hypertension and diabetes mellitus are prevalent chronic conditions, requiring long-term medication adherence for effective management. Non-compliance can lead to severe health complications and increased healthcare costs.
Objective: To evaluate medication compliance among hypertensive patients with known diabetes mellitus in Sindh, Pakistan, and identify key factors contributing to non-compliance.
Methods: This cross-sectional study included 381 participants from various cities in Sindh, selected through convenience sampling. Data were collected using a structured questionnaire covering demographic characteristics, socioeconomic status, and factors influencing medication compliance. Blood pressure was recorded using a sphygmomanometer. Ethical approval was obtained, and data were analyzed using SPSS version 25, with a p-value < 0.05 considered statistically significant.
Results: Of the 381 participants, 67.98% were fully compliant with their medication regimen, while 32.02% were non-compliant. The most common reasons for non-compliance were complex medication regimens (17.21%), side effects (16.39%), and financial constraints (13.93%). Socioeconomic status significantly influenced compliance, with lower compliance observed in the lower socioeconomic group (p < 0.05).
Conclusion: Despite a high compliance rate, a substantial portion of patients remain non-compliant due to regimen complexity and financial barriers. Targeted interventions, including simplified treatment plans and improved patient education, are necessary.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Yao Q, Liu C, Zhang Y, Xu L. Health-Related Quality Of Life Of People With Self-Reported Hypertension: A National Cross-Sectional Survey In China. Int J Environ Res Public Health. 2019;16(10):1721. doi: 10.3390/ijerph16101721.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global Burden Of Hypertension: Analysis Of Worldwide Data. Lancet. 2005;365(9455):217–23. doi: 10.1016/S0140-6736(05)17741-1.
Mohsen IM. Hypertension In Developing Countries: A Major Challenge For The Future. Curr Hypertens Rep. 2018;20(5):38. doi: 10.1007/s11906-018-0839-1.
Prabhakaran D, Jeemon P, Ghosh S, Shivashankar R, Ajay VS, Kondal D, et al. Prevalence And Incidence Of Hypertension: Results From A Representative Cohort Of Over 16,000 Adults In Three Cities Of South Asia. Indian Heart J. 2017;69(4):434–41. doi: 10.1016/j.ihj.2017.05.021.
Basit A, Tanveer S, Fawwad A, Naeem N, NDSP Members. Prevalence And Contributing Risk Factors For Hypertension In Urban And Rural Areas Of Pakistan; A Study From Second National Diabetes Survey Of Pakistan (NDSP) 2016–2017. Clin Exp Hypertens. 2020;42(3):218–24. doi: 10.1080/10641963.2019.1619753.
Shafi ST, Shafi T. A Survey Of Hypertension Prevalence, Awareness, Treatment, And Control In Health Screening Camps Of Rural Central Punjab, Pakistan. J Epidemiol Glob Health. 2017;7(2):135–40. doi: 10.1016/j.jegh.2017.01.001.
World Health Organization. Cardiovascular Diseases. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1.
Wikipedia. Pakistan. Available from: https://en.wikipedia.org/wiki/Pakistan.
Hassan A, Mahmood K, Allah Buksh H. Healthcare System Of Pakistan. Int J Adv Res Publ. 2017;1(4):170-3.
WHO EMRO. Health Service Delivery. Available from: https://www.emro.who.int/pak/programmes/service-delivery.html.
Barolia R, Sayani AH. Risk Factors Of Cardiovascular Disease And Its Recommendations In Pakistani Context. J Pak Med Assoc. 2017;67(11):1723–9.
Anjana RM, Ali MK, Pradeepa R, Deepa M, Datta M, Unnikrishnan R, et al. The Need For Obtaining Accurate Nationwide Estimates Of Diabetes Prevalence In India—Rationale For A National Study On Diabetes. Indian J Med Res. 2011;133:369–80.
Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The Significance Of Compliance And Persistence In The Treatment Of Diabetes, Hypertension And Dyslipidaemia: A Review. Int J Clin Pract. 2008;62:76–87.
Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, et al. Recommendations For Evaluating Compliance And Persistence With Hypertension Therapy Using Retrospective Data. Hypertension. 2006;47:1039–48.
Sweileh WM, Aker O, Hamooz S. Rate Of Compliance Among Patients With Diabetes Mellitus And Hypertension. An-Najah Univ J Res A Nat Sci. 2005;19:1–12.
Thrall G, Lip GY, Lane D. Compliance With Pharmacological Therapy In Hypertension: Can We Do Better, And How? J Hum Hypertens. 2004;18:595–7.
Srinivas G, Suresh E, Jagadeesan M, Amalraj E, Datta M. Treatment-Seeking Behavior And Compliance Of Diabetic Patients In A Rural Area Of South India. Ann N Y Acad Sci. 2002;958:420–4.
Rao CR, Kamath VG, Shetty A, Kamath A. Treatment Compliance Among Patients With Hypertension And Type 2 Diabetes Mellitus In A Coastal Population Of Southern India. Int J Prev Med. 2014;5(8):992-8.
Elahi A, Ali AA, Khan AH, Samad Z, Shahab H, Aziz N, et al. Challenges Of Managing Hypertension In Pakistan – A Review. Clin Hypertens. 2023;29(1):17. doi: 10.1186/s40885-023-00245-6.
Reddy Peddi D, Pallekonda H, Reddy V. Evaluation Of The Prevalence And Risk Factors Of Drug-Related Problems In Hypertension And Type 2 Diabetes Mellitus Patients At A Tertiary Care Hospital: A Cross-Sectional Study. Cureus. 2023;15(7)
. doi: 10.7759/cureus.42775.
Nutakor JA, Zhou L, Larnyo E, Addai-Danso S, Tripura D. Socioeconomic Status And Quality Of Life: An Assessment Of The Mediating Effect Of Social Capital. Healthcare (Basel). 2023;11(5):749. doi: 10.3390/healthcare11050749.
Rohatgi KW, Humble S, McQueen A, Hunleth JM, Chang SH, Herrick CJ, et al. Medication Adherence And Characteristics Of Patients Who Spend Less On Basic Needs To Afford Medications. J Am Board Fam Med. 2021;34(3):561–70. doi: 10.3122/jabfm.2021.03.200361.
Jimmy B, Jose J. Patient Medication Adherence: Measures In Daily Practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38.
Hamrahian SM, Maarouf OH, Fülöp T. A Critical Review Of Medication Adherence In Hypertension: Barriers And Facilitators Clinicians Should Consider. Patient Prefer Adherence. 2022;16:2749–57. doi: 10.2147/PPA.S368784.
Tiwary A, Rimal A, Paudyal B, Sigdel KR, Basnyat B. Poor Communication By Healthcare Professionals May Lead To Life-Threatening Complications: Examples From Two Case Reports. Wellcome Open Res. 2019;4:7. doi: 10.12688/wellcomeopenres.15042.1